Hb. Toksoy et al., SERUM CARNITINE, BETA-HYDROXYBUTYRATE AND AMMONIA LEVELS DURING VALPROIC ACID THERAPY, Turkish Journal of Pediatrics, 37(1), 1995, pp. 25-29
This study was performed in order to determine the effects of valproic
acid on serum free carnitine, beta-hydroxybutyrate and blood amamonia
. Serum free carnitine, beta-hydroxyhutyrate and blood ammonia levels
were measured in 24 epileptic children and in 24 age and sex-matched c
ontrols. The mean serum free carnitine level was significantly lower i
n patients taking valproic acid (33.5 +/- 13.1 nmol/ml) than in contro
l subjects (50.8 +/- 14.6 nmol/ml) (p < 0.001). The mean blood ammonia
level was significantly higher in patients receiving valproic acid (9
3.9 +/- 20.5 mu g/dl) than in controls (79.6 +/- 21.4 mu g/dl) (p < 0.
002). The mean serum beta-hydroxybutyrate level was significantly lowe
r in patients taking valproic acid (2.26 +/- 2.24 mg/dl) than in contr
ols (4.38 +/- 2.43 mg/dl) (p < 0.001). Our results support the decisio
n that valproic acid induces hypo-carnitinemia, hypoketonemia and an I
ncreased blood ammonia level.